Scheduled Napping Emerges as Most Reliable Fatigue Fix for Shift Workers in Systematic Review

Scheduled workplace napping is the most consistently effective intervention for reducing fatigue among shift workers, according to a systematic review published in BMC Public Health. The review, which synthesized 89 peer-reviewed studies published between 1988 and 2025, found that sleep and recovery interventions—primarily scheduled napping—reduced fatigue in 15 of 16 studies, a reported success rate of 93.8 percent. Yet the authors caution that this striking consistency comes with a major caveat: none of the sleep intervention studies were randomized controlled trials, meaning the finding requires confirmation through more rigorous experimental designs.

The research team, led by Mohammad Rahdar and colleagues, followed PRISMA guidelines and searched PubMed, Scopus, and Web of Science through November 8, 2025. Eligible studies had to evaluate workplace interventions among actively employed shift workers without confounding health conditions and had to measure fatigue outcomes directly. Because the included studies varied enormously in the interventions tested, the populations studied, and the outcome measures used, the authors did not attempt a formal meta-analysis. Instead, they synthesized findings narratively using an effect-direction vote-counting framework, classifying each intervention by its mechanism of action and assessing study quality with the Downs and Black checklist.

Beyond napping, the review found strong reported performance for digital and technology-assisted tools, which were effective in 8 of 9 studies (89 percent), and for lifestyle and behavioral interventions, which succeeded in 10 of 12 studies (83 percent). Work organization and environmental redesign—the broad category covering schedule changes, staffing adjustments, and modifications to the physical work environment—was the most heavily studied approach, appearing in 44 studies. It showed a more modest 66 percent effectiveness rate, with 9 studies finding no effect and 6 reporting increased fatigue. The authors argue that despite this moderate empirical record, job-centered schedule redesign remains the fundamental, system-wide approach because it does not depend on individual workers choosing to comply with a countermeasure.

Pharmacological and complementary countermeasures produced the most mixed picture, with only 5 of 8 studies showing effectiveness. One drug stood out: modafinil was consistently effective for acute vigilance deficits. However, the review notes that modafinil was tested only in small samples of medical undergraduates, military personnel, and aviation staff, limiting how far its results can be generalized to the broader shift-working population. Notably, pharmacological studies had the highest proportion of high-quality trials of any intervention category, at 75 percent, in sharp contrast to the entirely non-randomized sleep intervention literature.

Perhaps the review’s most consequential finding is that high reported effectiveness did not correlate with methodological rigor. Only 19 of the 89 studies—21.35 percent—were randomized controlled trials, and fewer than half demonstrated good or excellent methodological quality on the Downs and Black checklist. This means that interventions appearing highly effective in the vote-counting analysis may simply have been tested less rigorously, while some interventions with weaker reported results may have been held to higher evidentiary standards. The authors emphasize that intervention effectiveness must always be interpreted alongside the quality of the underlying evidence.

The review’s scope is notable for its breadth. Most previous reviews have focused on single occupations or isolated countermeasures, limiting cross-industry synthesis. By contrast, this analysis drew from studies across diverse shift-working sectors, with healthcare accounting for the largest share at 46 of the 89 included studies. Shift work disrupts circadian regulation, impairs sleep quality, and hinders recovery between shifts, all of which increase occupational safety risks—a burden the authors frame as spanning industries rather than being confined to any single profession.

The authors’ conclusions assign distinct roles to each intervention category. Scheduled napping showed the most reliable fatigue reduction, though the absence of randomized designs means this finding should be treated as promising rather than settled. Digital and behavioral interventions are positioned as valuable, context-dependent approaches whose effectiveness likely depends on the specific workplace and workforce. Schedule redesign, meanwhile, is framed as the backbone of fatigue management precisely because it operates at the system level rather than relying on individual behavior change.

Looking forward, the review identifies clear priorities for the field: standardized fatigue metrics so that studies can be compared and pooled, randomized designs to establish causal effects, and greater attention to underrepresented, high-risk occupational sectors. The dominance of healthcare studies in the evidence base suggests that findings drawn from nurses and physicians may not automatically transfer to other shift-working populations, such as industrial, transport, or emergency services workers. The review was published as an open-access article, with the version released ahead of the final Version of Record and subject to further editorial edits.

Subject of Research: Interventions to mitigate fatigue in shift workers

Article Title: Interventions to mitigate fatigue in shift workers: a systematic review

Article References: Rahdar, M., Charkhabi, S. A., Zare, M., Rahgoshay, N., & Kazemi, R. (2026). Interventions to mitigate fatigue in shift workers: a systematic review. BMC Public Health. https://doi.org/10.1186/s12889-026-29700-3

Image Credits: AI Generated

DOI: 10.1186/s12889-026-29700-3

Keywords: shift work, fatigue, systematic review, scheduled napping, sleep interventions, modafinil, occupational health, circadian rhythm, work schedule redesign, BMC Public Health, evidence quality, randomized controlled trials